TTE has been adopted in many therapeutic areas, including cystic fibrosis (CF).5, 7 CF is a life-shortening condition, caused by mutations in the CF transmembrane conductance regulator (CFTR) gene, which affects multiple organ systems, including the lungs, liver, digestive tract and reproductive organs. Here, CFTR is linked to cystic fibrosis.